NKF(SH:603707) Zheng Quan Zhi Xing·2025-07-01 16:20Summary of Key Points Core Viewpoint - The announcement details the conversion results and share changes related to the "Jianyou Convertible Bonds" issued by Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd, highlighting the low conversion rate and the remaining unconverted bonds. Group 1: Conversion Status - As of June 30, 2025, a total of RMB 719,000 of "Jianyou Convertible Bonds" have been converted into ordinary shares, with RMB 7,000 of the bonds being repurchased [1][3] - The amount of unconverted "Jianyou Convertible Bonds" as of June 30, 2025, is RMB 502,464,000, which represents 99.86% of the total issuance [1][3] Group 2: Issuance Overview - The company issued 5,031,900 convertible bonds with a total value of RMB 5.0319 billion, with a maturity of 6 years, approved by the China Securities Regulatory Commission [1][2] - The bonds were listed on the Shanghai Stock Exchange starting from May 22, 2020, under the code "113579" [1][2] Group 3: Conversion Price Adjustments - The initial conversion price was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing the price down to RMB 24.34 per share effective from June 5, 2025 [2][3] Group 4: Share Capital Changes - The total share capital remained unchanged at 1,615,634,969 shares as of June 30, 2025, with no new shares issued from the conversion of the bonds [4]